Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
18.53
-0.09 (-0.48%)
Nov 21, 2024, 3:29 PM EST - Market open
Summit Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 13,665 | 1,829 | 897 | 263 | 387 | 537 | |
| Market Cap Growth | 1151.11% | 103.94% | 241.23% | -32.01% | -28.06% | 152.03% | |
| Enterprise Value | 13,277 | 1,737 | 779 | 184 | 366 | 521 | |
| Last Close Price | 18.62 | 2.61 | 4.25 | 2.69 | 4.70 | 1.60 | |
| PS Ratio | - | - | 1272.24 | 145.30 | 449.56 | 663.04 | |
| PB Ratio | 31.34 | 23.54 | 7.08 | 3.16 | 4.87 | 6.81 | |
| P/TBV Ratio | 37.45 | 24.13 | 7.18 | 3.71 | 5.87 | 8.43 | |
| EV/Sales Ratio | - | - | 1105.42 | 101.96 | 425.47 | 642.56 | |
| Debt / Equity Ratio | 0.07 | 1.37 | 4.10 | 0.03 | 0.01 | 0.01 | |
| Asset Turnover | - | - | 0.00 | 0.02 | 0.01 | - | |
| Quick Ratio | 8.26 | 9.17 | 9.15 | 3.47 | 3.85 | 5.05 | |
| Current Ratio | 8.31 | 9.30 | 16.93 | 3.80 | 4.41 | 5.78 | |
| Return on Equity (ROE) | -73.21% | -601.85% | -75.05% | -108.89% | -66.57% | - | |
| Return on Assets (ROA) | -31.47% | -12.79% | -10.43% | -49.91% | -32.92% | - | |
| Return on Capital (ROIC) | -33.55% | -13.38% | -11.09% | -64.91% | -40.97% | - | |
| Earnings Yield | -1.43% | -33.62% | -8.78% | -33.71% | -13.63% | -5.91% | |
| FCF Yield | -0.82% | -4.20% | -4.71% | -27.73% | -12.55% | -4.26% | |
| Buyback Yield / Dilution | -28.70% | -220.50% | -109.60% | -32.67% | -111.78% | -90.55% | |
| Total Shareholder Return | -28.70% | -220.50% | -109.60% | -32.67% | -111.78% | -90.55% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.